Creatine appears safe for people with diabetes who have normal kidney function, but those with any stage of chronic kidney disease should seek specialist advice before using it
GLP-1 therapy is an investment that needs a strategy to protect it
NF1 is characterized by multiple benign neurofibromas, caf-au-lait spots, and an increased lifetime risk (approximately 813%) of developing MPNST (Evans et al., 2021)
The evidence for this is poor and expert opinion suggests as long as you have enough weight to lose, that your milk should be unaffected (Hale)
Servings Per Container: 500Mg
Drugs targeting weight management accounted for nearly half of the increase in drug spend in 2024, and the average list price for a GLP-1 is around $1,000 per month